Georg Kunz

Marienhospital Bottrop GGmbH
Bottrop, NW, DE 
Marienhospital Bottrop GGmbH
Bottrop, NW, DE 

Overview

Georg Kunz practices practicing medicine in Bottrop, Germany.

His clinical expertise encompasses Breast Cancer and Triple-Negative Breast Cancer.

He is actively involved in clinical research, co-authoring 17 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Marienhospital Bottrop gGmbH
Bottrop, NW, Germany
Other Locations
St. Johannes Hospital, Dortmund, NW, Germany
Neu Isenburg, HE, Germany
Buch, BE, Germany
Henriettenstiftung
Hannover, NI, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3

16 Total Publications

Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.
Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 10, 2025

Frequently Asked Questions about Georg Kunz

Is Georg Kunz a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Georg Kunz is classified as an Experienced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Georg Kunz participate in research or clinical trials?

Yes. Georg Kunz has published 16 articles and abstracts on conditions like Breast Cancer. You can view a list of Georg Kunz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kunz's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile